- Economic impact of sotagliflozin among patients with heart failure and type 2 diabetesby Jason Shafrin (Healthcare Economist) on March 31, 2025
That is the title of a new paper with Shanshan Wang, Jaehong Kim, and Slaven Sikirica that has the subtitle “Budget impact analysis from the US payer perspective.” That abstract is below: BACKGROUND:Heart failure (HF) is a leading cause of […]
- How Real-World Data Can Support Label Extension And Safer Use Of Novel Therapiesby Jenna Phillips (MedCity News) on March 31, 2025
Engaging in data sharing, observational cohort research, and deeper analysis of available data to yield further insights can drive improved results for patients, making label and cohort extension faster and more robust. The post How Real-World Data […]
- Two Chairs Expands Mental Health Services to 19 More Statesby Katie Adams (MedCity News) on March 30, 2025
Two Chairs, which offers hybrid behavioral health care, expanded its presence from three states to 22 states. This expansion gives millions of people access to therapy services, as Two Chairs’ services are now available to 75% of the U.S. […]
- What’s Private Equity’s Impact on Intellectual and Developmental Disability Services?by Marissa Plescia (MedCity News) on March 30, 2025
A new report from the Private Equity Stakeholder Project reveals that private equity firms have been increasingly acquiring intellectual and developmental disability providers and implementing cost-cutting strategies that reduce care quality. The […]
- PCR Comes to the Home With FDA Authorization of Visby’s OTC Sexual Health Testby Frank Vinluan (MedCity News) on March 30, 2025
The FDA granted marketing authorization to a Visby Medical at-home PCR test for three common sexually transmitted infections. The Visby test yields results in about 30 minutes. The post PCR Comes to the Home With FDA Authorization of Visby’s OTC […]
- The Case for 340B Done Rightby Clifford W. Knights (MedCity News) on March 30, 2025
It’s critical that healthcare organizations delivering on the program’s promise not be torpedoed by the “bad actors” The post The Case for 340B Done Right appeared first on MedCity News.
- Unlocking the Potential: Medication Assisted Therapies for Opioid Substance Use Disorder in Correctional Settingsby Jeffrey Alvarez (MedCity News) on March 30, 2025
To reduce overdose rates in the U.S., leaders must recognize the impact of medication-assisted treatment in correctional facilities. The post Unlocking the Potential: Medication Assisted Therapies for Opioid Substance Use Disorder in Correctional […]
- Linksby Jason Shafrin (Healthcare Economist) on March 28, 2025
Measles outbreak expands to 19 states. Commercial health plan coverage of accelerated approval drugs…and a recent case study. Extending IRA drug price negotiation to commercial plans? ‘Kennedy Turns to a Discredited Vaccine Skeptic for Autism […]
- Report: How Medicaid/SNAP Cuts Could Affect the Economyby Marissa Plescia (MedCity News) on March 28, 2025
Medicaid and SNAP cuts could lead to 1 million jobs lost in just 2026, according to a new report from the Commonwealth Fund and the George Washington University Milken Institute School of Public Health. The post Report: How Medicaid/SNAP Cuts Could […]
- Most Healthcare Providers Remain Highly Vulnerable to Ransomware Attacksby Katie Adams (MedCity News) on March 28, 2025
About 90% of healthcare organizations are insecurely connected to the internet and running systems vulnerable to exploitation by ransomware gangs, according to new research. It also found that 78% of providers have made ransomware payments of […]
- Novo Nordisk Lands Lexicon Pharma Obesity Drug With Potential to Pair With GLP-1sby Frank Vinluan (MedCity News) on March 28, 2025
Novo Nordisk gets global rights to Lexicon Pharmaceuticals’ LX9851, an oral small molecule with a first-in-class approach to sparking weight loss. The licensing agreement comes months after Lexicon reported encouraging preclinical data from tests […]
- How Community Health Programs are Reducing 911 Calls and Helping Patients Before Emergenciesby Joe Graw (MedCity News) on March 28, 2025
By focusing on prevention, collaboration, and data-driven innovation, community health programs are ensuring resources are used more effectively and patient care is proactive rather than reactive. The post How Community Health Programs are Reducing […]
- Bridging the AI Gap in Local Health: Practical Steps for Adoptionby John Auerbach and Eddie Kirkland (MedCity News) on March 28, 2025
By prioritizing staff education, starting small with practical applications, and establishing clear guidelines, local health departments can lay the foundation for sustainable AI adoption. This approach ultimately enhances efficiency, improves […]
- What is the “Administration for a Healthy America”?by Jason Shafrin (Healthcare Economist) on March 28, 2025
This is a new organization that Robert F. Kennedy Jr. aims to create, consolidating the functions of many federal health organizations and cutting significant staff. The Guardian reports: Robert F Kennedy Jr said the nation’s health agencies […]
- Startup Launches To Offer Payers an AI-Powered Contact Center Platformby Marissa Plescia (MedCity News) on March 27, 2025
TrampolineAI launched out of Redesign Health to help health plans with their contact centers. The post Startup Launches To Offer Payers an AI-Powered Contact Center Platform appeared first on MedCity News.
- Rare Metabolic Disease That Leads to Childhood Obesity Gets Its First FDA-Approved Drugby Frank Vinluan (MedCity News) on March 27, 2025
Soleno Therapeutics’ Vykat XR is now FDA approved for treating hyperphagia, or excessive hunger, in patients with Prader-Willi syndrome. The once-daily pill is the first approved therapy for this rare disease, a leading cause of childhood obesity. […]
- NIH Cuts: A Push for Efficiency or a Blow to US Healthcare Innovation?by Katie Adams (MedCity News) on March 27, 2025
The Trump administration recently cancelled billions of dollars in funding to the NIH. Healthcare experts say the funding cuts will delay the pace of medical research in the U.S. — which will not only hamper the commercialization of life-saving […]
- MedCity FemFwd: The Link Between Intimate Partner Violence and Healthby Marissa Plescia (MedCity News) on March 27, 2025
In this episode, we’re joined by Dr. Audrey Jiricko, senior medical director of women’s health at Intermountain Health. She discusses how the organization is screening women for intimate partner violence. The post MedCity FemFwd: The Link […]
- Why Playing Nice is a Competitive Advantageby Guillaume Castel (MedCity News) on March 27, 2025
When systems integrate better, every minute saved by removing roadblocks is a minute given back to clinicians and patient care. It’s time for vendors in this space to treat interoperability as a core business strategy rather than a buzzword or […]
- Changes in Nurse Staffing Answer Clinician Demandsby Luidgi Faubert (MedCity News) on March 27, 2025
[Sponsored] The ongoing nursing shortage facilitates high turnover rates since nurses know they won’t have difficulties finding new jobs. In order to retain and attract staff, it’s in a facility’s best interest to understand what nurses want. […]
- The Challenges Of HCPs Accessing Reliable Online Medicines Information and What Pharma Companies Can Do To Improve Information Sharingby Rich Cooper (MedCity News) on March 27, 2025
Enhancing the accessibility of trustworthy medicines information and the availability of SRDs while also improving search technologies will ensure HCPs can quickly obtain accurate answers to their specific questions. The post The Challenges Of […]
- Report: Traditional Drug Costs Outpace Specialty Due to GLP-1 Demandby Marissa Plescia (MedCity News) on March 26, 2025
The annual growth rate of spending for traditional drugs increased from 2.1% in 2021 to 12.8% in 2024, according to Evernorth Research Institute. The post Report: Traditional Drug Costs Outpace Specialty Due to GLP-1 Demand appeared first on MedCity […]
- FDA Approves First-in-Class GSK Antibiotic for Common Type of Urinary Tract Infectionby Frank Vinluan (MedCity News) on March 26, 2025
The FDA approved GSK antibiotic Blujepa as a treatment for uncomplicated urinary tract infections. The drug’s novel mechanism of action addresses a broader range of pathogens and could offer a way to lower the potential for drug resistance. The […]
- Check Out the Future of Medtech: A Preview of Device and Diagnostics INVEST Pitch Perfect Finalistsby Stephanie Baum (MedCity News) on March 26, 2025
Finalists in the Pitch Perfect contest at INVEST, scheduled for May 20-21 in Chicago at the Willis Tower, span medtech for asthma, diabetic neuropathy, Parkinson’s disease, and more. Register today! The post Check Out the Future of Medtech: A […]
- Marketing’s Untapped Opportunity in the Medical Product Lifecycleby Chuck Serrin (MedCity News) on March 26, 2025
If marketing’s participation isn’t already incorporated into a company’s official product development process, they’re missing the boat. The post Marketing’s Untapped Opportunity in the Medical Product Lifecycle appeared first on MedCity […]